Department of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy.
Blood. 2010 Feb 11;115(6):1185-93. doi: 10.1182/blood-2009-06-228676. Epub 2009 Dec 11.
We hypothesized that progression of monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma (MM) reflects the escape of transformed plasma cells from T-cell recognition because of impaired antigen processing-presenting machinery (APM). We studied plasma cells and CD8(+) T cells from bone marrow of 20 MGUS patients, 20 MM patients, and 10 control patients. Immunofluorescence and flow cytometry revealed significantly different patterns of APM component expression in plasma cells from the 3 groups. Compared with control patients, MM samples had lower expression of proteasome subunits and peptide transporters and greater expression of chaperones, considering both percentages of stained cells and molecular equivalents of soluble fluorochrome. MGUS samples had intermediate percentages of stained cells but molecular equivalents of soluble fluorochrome similar to control patients. Real-time polymerase chain reaction documented that APM changes occurred at the transcriptional level. Cytotoxicity assays demonstrated that MGUS CD8(+) T cells lysed autologous transformed plasma cells more than MM CD8(+) T cells did. MGUS progression correlated directly with calnexin, calreticulin, and tapasin and indirectly with delta, LMP2, and LMP10 expression levels; MM disease status did not correlate with APM levels. APM changes may allow transformed plasma cells to elude immunesurveillance in the MGUS-MM pathogenetic sequence.
我们假设单克隆丙种球蛋白异常(MGUS)向多发性骨髓瘤(MM)的进展反映了转化浆细胞逃避 T 细胞识别,因为抗原加工呈递机制(APM)受损。我们研究了 20 例 MGUS 患者、20 例 MM 患者和 10 例对照患者的骨髓浆细胞和 CD8+T 细胞。免疫荧光和流式细胞术显示 3 组浆细胞中 APM 成分表达的模式明显不同。与对照患者相比,MM 样本中蛋白酶体亚基和肽转运蛋白的表达较低,而伴侣蛋白的表达较高,同时考虑到染色细胞的百分比和可溶性荧光素的分子等效物。MGUS 样本的染色细胞百分比中等,但与对照患者相似的可溶性荧光素分子等效物。实时聚合酶链反应记录了 APM 变化发生在转录水平。细胞毒性测定表明,MGUS CD8+T 细胞裂解自身转化的浆细胞多于 MM CD8+T 细胞。MGUS 进展与钙网蛋白、钙结合蛋白和 tapasin 直接相关,与 delta、LMP2 和 LMP10 表达水平间接相关;MM 疾病状态与 APM 水平无关。APM 变化可能使转化的浆细胞在 MGUS-MM 发病序列中逃避免疫监视。